These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 8431499

  • 21. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Aoki T, Nishimura H, Nakagawa S, Kojima J, Suzuki H, Tamaki T, Wada Y, Yokoo N, Sato F, Kimata H, Kitahara M, Toyoda K, Sakashita M, Saito Y.
    Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
    [Abstract] [Full Text] [Related]

  • 22. [Porphyria cutanea tarda induced by HMG CoA reductase inhibitors: simvastatin, pravastatin].
    Perrot JL, Guy C, Bour Guichenez G, Amigues O, Servoz J, Cambazard F.
    Ann Dermatol Venereol; 1994 Aug; 121(11):817-9. PubMed ID: 7631993
    [Abstract] [Full Text] [Related]

  • 23. Determination of lovastatin acid in serum by gas chromatography/mass spectrometry.
    Wang-Iverson D, Ivashkiv E, Jemal M, Cohen AI.
    Rapid Commun Mass Spectrom; 1989 May; 3(5):132-4. PubMed ID: 2520234
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The interaction of diltiazem with lovastatin and pravastatin.
    Azie NE, Brater DC, Becker PA, Jones DR, Hall SD.
    Clin Pharmacol Ther; 1998 Oct; 64(4):369-77. PubMed ID: 9797793
    [Abstract] [Full Text] [Related]

  • 26. Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin.
    De Vries AC, Vermeer MA, Bredman JJ, Bär PR, Cohen LH.
    Exp Eye Res; 1993 Apr; 56(4):393-9. PubMed ID: 8500554
    [Abstract] [Full Text] [Related]

  • 27. Electrical myotonia of rabbit skeletal muscles by HMG-CoA reductase inhibitors.
    Sonoda Y, Gotow T, Kuriyama M, Nakahara K, Arimura K, Osame M.
    Muscle Nerve; 1994 Aug; 17(8):891-7. PubMed ID: 8041396
    [Abstract] [Full Text] [Related]

  • 28. P-glycoprotein has differential effects on the disposition of statin acid and lactone forms in mdr1a/b knockout and wild-type mice.
    Chen C, Lin J, Smolarek T, Tremaine L.
    Drug Metab Dispos; 2007 Oct; 35(10):1725-9. PubMed ID: 17640956
    [Abstract] [Full Text] [Related]

  • 29. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 30. Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers.
    Pierno S, De Luca A, Tricarico D, Roselli A, Natuzzi F, Ferrannini E, Laico M, Camerino DC.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1490-6. PubMed ID: 8531120
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
    Aronson JK, Ng LL.
    Q J Med; 1990 Feb; 74(274):111-5. PubMed ID: 2111916
    [No Abstract] [Full Text] [Related]

  • 33. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
    Eckernäs SA, Roos BE, Kvidal P, Eriksson LO, Block GA, Neafus RP, Haigh JR.
    Br J Clin Pharmacol; 1993 Mar; 35(3):284-9. PubMed ID: 8471404
    [Abstract] [Full Text] [Related]

  • 34. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
    Neuvonen PJ, Kantola T, Kivistö KT.
    Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
    [Abstract] [Full Text] [Related]

  • 35. A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors.
    Newman A, Clutterbuck RD, Powles RL, Catovsky D, Millar JL.
    Leuk Lymphoma; 1997 Feb; 24(5-6):533-7. PubMed ID: 9086443
    [Abstract] [Full Text] [Related]

  • 36. Cytosolic Ca2+ increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors.
    Nakahara K, Yada T, Kuriyama M, Osame M.
    Biochem Biophys Res Commun; 1994 Aug 15; 202(3):1579-85. PubMed ID: 8060342
    [Abstract] [Full Text] [Related]

  • 37. Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative.
    Slater EE, MacDonald JS.
    Drugs; 1988 Aug 15; 36 Suppl 3():72-82. PubMed ID: 3076125
    [Abstract] [Full Text] [Related]

  • 38. Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans.
    Pentikainen PJ, Saraheimo M, Schwartz JI, Amin RD, Schwartz MS, Brunner-Ferber F, Rogers JD.
    J Clin Pharmacol; 1992 Feb 15; 32(2):136-40. PubMed ID: 1613123
    [Abstract] [Full Text] [Related]

  • 39. Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug.
    Vickers S, Duncan CA, Chen IW, Rosegay A, Duggan DE.
    Drug Metab Dispos; 1990 Feb 15; 18(2):138-45. PubMed ID: 1971563
    [Abstract] [Full Text] [Related]

  • 40. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW.
    Cardiology; 1990 Feb 15; 77 Suppl 4():14-21. PubMed ID: 2073667
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.